June 340Buzz: Are you on the 340B energy bus?
Summary
As we approach mid-year 2021 — in the second year of a worldwide pandemic, amidst a polarized political environment fraught with negativity, ill-will and energy vampires of every stripe — there are still many reasons to stay positive, energized and even optimistic about the work we’re doing and the people we’re serving under the 340B program. Most experts agree that the major tenets of Obamacare and the 340B program would appear to be secure for the foreseeable future and that if the fundamentals of the law were to be changed, it would require Congressional legislation to do so. Biden proposes to rescind insulin rule — The Biden administration formally announced plans to rescind the Trump administration’s controversial final rule requiring community health centers to pass along all 340B drug discount savings on insulin and injectable epinephrine to low-income patients as a condition for keeping their federal health center program grants. Biden’s proposed 2022 budget has been published — Interesting highlights include expanding HHS’s general 340B authority to reform the program, with suggested language to allow them to audit a covered entity with the purpose of reviewing how 340B benefits are being utilized. As always, whatever challenges the industry faces, Sentry will be there along the way as a voice for covered entities and to support you in your effort to optimize the 340B program and serve its vulnerable patients.
Classifications
AskAI Classifications
LabelsLinked Companies
